hope research center

nav

research-page

Filter menu

Article Types

Clear

Text availability

Clear

Species

Clear

Publication dates

Clear
Search results
Items: 90 to 100 of 94

  1. Can we modify assisted reproductive technology practice to broaden reproductive care access?

    Richard J. Paulsona, Bart C. J. M. Fauserb, Lan T. N. Vuongc, and Kevin Doodyd

     Fertil Steril. 2016 May;105(5) - 2016-05-15

    DOI https://doi.org/10.1016/j.fertnstert.2016.03.013

  2. Gonadotropin-releasing hormone agonist (GnRHa) trigger in oocyte donors co-treated with a GnRH antagonist - a dose-finding study

    Thi Ngoc Lan Vuonga,b, Manh Tuong Hob,c, Tan Duc Had,e, Huy Tuan Phungb, Gia Bao Huynhb, and Peter Humaidanf,g

     Fertil Steril. 2016 May;105(5):1138-1143 - 2015-10-30

    DOI http://dx.doi.org/10.1016/j.fertnstert.2015.10.014

  3. Predictive Value of AMH, FSH and AFC for Determining Ovarian Response in Vietnamese Women Undergoing Assisted Reproductive Technologies: A Prospective Study

    TNL Vuong1*, MT Vo1 and MT Ho2,3

     JFIV Reprod Med Genet 2015, 3:3 - 2015-06-09

    DOI: http://dx.doi.org/10.4172/2375-4508.1000151

  4. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥ 35 years: a randomized controlled trial

    T.N.L. Vuong1,2,*, H.T. Phung2, and M.T. Ho2,3

     Hum Reprod. 2015 May;30(5):1188-95 - 2015-02-09

    DOI: https://doi.org/10.1093/humrep/dev038